Previous reports suggest that KDM4B silencing inhibits the activity of STAT3 signaling in colorectal cancer (Chen et al. 2014; Deng et al. 2018), and thus, we tried to detect whether KDM4B can regulate the activity of STAT3 signaling in RA FLS. This evidence concerns the gene KDM4B and colorectal cancer.